patsnap.com/resources/blog/articles/neuromorphic-computing-chip-patents-surge-401-in-2025/ [Translated from EN to English]
→ View original post on X — @kimmonismus, 2026-04-05 15:33 UTC
By
–
patsnap.com/resources/blog/articles/neuromorphic-computing-chip-patents-surge-401-in-2025/ [Translated from EN to English]
→ View original post on X — @kimmonismus, 2026-04-05 15:33 UTC
By
–
Yup – If you want your agent to feel human and to get a lot done it has a steep true price right now As people get better at setting up agents providers will throttle usage and dial in their pricing so they don’t lose money Running local models will be key to AI autonomy Ryan Carson (@ryancarson) The cost to run a truly useful Chief of Staff @openclaw on Opus 4.6 is $100-200 per day on the API. — https://nitter.net/ryancarson/status/2040730811805118633#m
→ View original post on X — @clementdelangue, 2026-04-05 14:52 UTC
By
–
You got the stats from Lehman Brothers?
By
–
⚡ Most leaders think higher AI investment leads to better performance. The real shift is that investment no longer predicts outcomes.
— Syed Ijlal Hussain (@sijlalhussain) 5 avril 2026
As Roland Berger highlights, organizations now split into distinct groups despite similar levels of AI commitment. High investment and rapid… pic.twitter.com/YxHvWcFoWT
⚡ Most leaders think higher AI investment leads to better performance. The real shift is that investment no longer predicts outcomes. As Roland Berger highlights, organizations now split into distinct groups despite similar levels of AI commitment. High investment and rapid deployment are widespread, but performance is increasingly uneven. 1️⃣ Structural Shift: Only a small group of “industrializers” convert AI into real value. They align strategy, execution, and operating models. 2️⃣ Leadership Blind Spot: Nearly half of organizations remain “observers” or “stalled,” running pilots or scaling activity without translating it into returns. 3️⃣ Strategic Risk: High spend without execution discipline creates the illusion of progress. Organizations move fast, but stay in the same place. This is why performance divergence is accelerating. It is no longer about access to AI. It is about how it is operationalized. The real question is not who is investing more. It is who is actually converting AI into enterprise value. via Roland Berger Why AI deployment is outpacing value realization – and how organizations can close the gap rolandberger.com/en/Insights… @corixpartners @Transform_Sec @Corix_JC @ILoveBooks786 @COSTESLionelEr @ramonvidall @RLDI_Lamy @FrRonconi @timo_vi @Nicochan33 @NathaliaLeHen @TCyberCast @arigatou163 @VivMilanoFSL @MathildaLoco @faryus88 @bbailey39 @BindIdeas971 @FmFrancoise @EduFirst @rameshambastha @DonaldGavis @ricardo_ik_ahau @sulefati7 @ozsilverfox @BCAgroup @9SManagement @O_Berard @DavidTaboada @yd_engoue @giuliog @Hajer_Alqassimi @EdwardHarkins @Evanskipropcrim @ranya_artistry @Howie7951 @iamtunslaw @gvalan

By
–
👑👑👑👑👑👑👑👑 MONTREAL.AI (@Montreal_AI) 🌌 DiscoveryPrime — the first live premium procurement, fully revealed. montrealai.github.io/discove… Where intelligence is discovered, proven, and deployed. Not just selecting talent.
Allocating the world's most powerful capabilities. #AIAgents #AGIJobs #Jobs [Translated from EN to English]
→ View original post on X — @ceobillionaire, 2026-04-05 13:38 UTC

By
–
🌌 DiscoveryPrime — the first live premium procurement, fully revealed. montrealai.github.io/discove… Where intelligence is discovered, proven, and deployed. Not just selecting talent. Allocating the world’s most powerful capabilities. #AIAgents #AGIJobs #Jobs
→ View original post on X — @ceobillionaire, 2026-04-05 13:23 UTC

By
–
Anthropic just acquired AI biotech startup Coefficient Bio for ~$400M, a team of fewer than 10 people building AI that can plan drug R&D, manage clinical regulatory strategy, and identify new drug opportunities. Exactly has he invisioned in his blog "Machines of Loving Grace".
By
–
The companies building agent strategies now will have first-mover advantages in the largest market opportunity ever.
By
–
There are 8,300 companies in my lists. Most of them will go away because they can’t get anyone to care about them. Roy at least got us to pay attention.
By
–
The South African woman who studied biomedical engineering in Japan and launched tech startup backed by Microsoft After completing a Master's degree in biomedical engineering in Japan, Pelonomi Moiloa returned to South Africa to launch Lelapa AI. mybroadband.co.za/news/ai/63…
→ View original post on X — @taryl_ogle, 2026-04-05 06:00 UTC